SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001562762-17-000015
Filing Date
2017-02-10
Accepted
2017-02-10 09:23:29
Documents
4
Period of Report
2017-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20170210x8k.htm 8-K 47493
2 EX-3.1 plse-20170210xex3_1.htm EX-3.1 89609
3 EX-10.1 plse-20170210xex10_1.htm EX-10.1 411699
4 EX-99.1 plse-20170210xex99_1.htm EX-99.1 25216
  Complete submission text file 0001562762-17-000015.txt   575602
Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 90401
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 90401 650-697-3939
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1217
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 17589917
SIC: 3841 Surgical & Medical Instruments & Apparatus